Studies have explored the impact of rosuvastatin on various types of cancer, including breast cancer, colorectal cancer, prostate cancer, and lung cancer. However, the results have been mixed and inconclusive. For example, some observational studies have indicated a lower incidence of colorectal cancer in patients taking statins, whereas other studies have shown no significant impact. Clinical trials and more extensive research are needed to draw definitive conclusions.
